BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9203845)

  • 1. Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy.
    Reubi JC
    Q J Nucl Med; 1997 Jun; 41(2):63-70. PubMed ID: 9203845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging tumors with peptide-based radioligands.
    Behr TM; Gotthardt M; Barth A; Béhé M
    Q J Nucl Med; 2001 Jun; 45(2):189-200. PubMed ID: 11476170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic applications of radiolabeled peptides in nuclear endocrinology.
    Behr TM; Béhé M; Becker W
    Q J Nucl Med; 1999 Sep; 43(3):268-80. PubMed ID: 10568142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin and the concept of peptide receptor scintigraphy in oncology.
    Lamberts SW; Reubi JC; Krenning EP
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):1-5. PubMed ID: 7992074
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical application of somatostatin receptor imaging.
    Reichlin S
    J Clin Endocrinol Metab; 1990 Sep; 71(3):564-5. PubMed ID: 2168429
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging.
    Reubi JC
    J Nucl Med; 1995 Oct; 36(10):1846-53. PubMed ID: 7562054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors on tumors studied with radionuclide scintigraphy.
    Larson S
    J Nucl Med; 1991 Jun; 32(6):1189-91. PubMed ID: 1646303
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on radiolabeled somatostatin analogues in rats and in patients.
    Breeman WA; Bakker WH; De Jong M; Hofland LJ; Kwekkeboom DJ; Kooij PP; Visser TJ; Krenning EP
    Q J Nucl Med; 1996 Sep; 40(3):209-20. PubMed ID: 8961800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
    Krenning EP; Kwekkeboom DJ; de Jong M; Visser TJ; Reubi JC; Bakker WH; Kooij PP; Lamberts SW
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):6-14. PubMed ID: 7992084
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.
    Reubi JC; Waser B; Laissue JA; Gebbers JO
    Cancer Res; 1996 Apr; 56(8):1922-31. PubMed ID: 8620515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
    Behr TM; Jenner N; Béhé M; Angerstein C; Gratz S; Raue F; Becker W
    J Nucl Med; 1999 Jun; 40(6):1029-44. PubMed ID: 10452322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mack Forster Award Lecture. Receptor nuclear medicine: vasointestinal peptide and somatostatin receptor scintigraphy for diagnosis and treatment of tumour patients.
    Virgolini I
    Eur J Clin Invest; 1997 Oct; 27(10):793-800. PubMed ID: 9373755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-based probes for cancer imaging.
    Reubi JC; Maecke HR
    J Nucl Med; 2008 Nov; 49(11):1735-8. PubMed ID: 18927341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor imaging of human diseases using radiolabeled peptides.
    Reubi JC; Lamberts SJ; Krenning EP
    J Recept Signal Transduct Res; 1995; 15(1-4):379-92. PubMed ID: 8903952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor scintigraphy of non-neuroendocrine cancers with In-111 pentetreotide.
    Limouris GS; Rassidakis A; Kondi-Paphiti A; Triantafyllou N; Manetou A; Gennatas K; Vitoratos N; Gregoriou O; Stavraka A; Vlahos L
    Hybridoma; 1997 Feb; 16(1):133-7. PubMed ID: 9085140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals.
    Bakker WH; Krenning EP; Breeman WA; Koper JW; Kooij PP; Reubi JC; Klijn JG; Visser TJ; Docter R; Lamberts SW
    J Nucl Med; 1990 Sep; 31(9):1501-9. PubMed ID: 1975618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
    Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I
    J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man.
    Bakker WH; Krenning EP; Breeman WA; Kooij PP; Reubi JC; Koper JW; de Jong M; Laméris JS; Visser TJ; Lamberts SW
    J Nucl Med; 1991 Jun; 32(6):1184-9. PubMed ID: 1646302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
    Krenning EP; Bakker WH; Kooij PP; Breeman WA; Oei HY; de Jong M; Reubi JC; Visser TJ; Bruns C; Kwekkeboom DJ
    J Nucl Med; 1992 May; 33(5):652-8. PubMed ID: 1349039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.